Precision in Clinical Trials Oncology (PCTO) Summit Boston 2026

Precision in Clinical Trials Oncology (PCTO) Summit Boston 2026 is organized by Precision Evolution Global (PEG) and will be held from Nov 16 - 17, 2026 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Description:
Oncology Clinical Trials Conference Boston 2026 is a leading roadmap. The summit fosters advanced innovations, patient-centered research, and operational strategy in oncology study design. The summit is hosted within the Boston-Cambridge oncology corridor. Additionally, the event is held at a location known for pioneering breakthroughs in targeted cancer treatments, immunotherapy, and precision oncology.

This dynamic and advanced Boston oncology research ecosystem combines major innovators including Vertex Pharmaceuticals, AstraZeneca, Novartis Oncology, Bristol Myers Squibb, Merck & Co., Biogen, and Pfizer. The summit is home to the world's renowned cancer research departments such as MIT Koch Institute for Integrative Cancer Research, Harvard Medical School, Boston Children's Hospital, Massachusetts General Hospital Cancer Center, and Dana-Farber Cancer Institute.

Summit Features:
The Cancer Clinical Research Conference 2026 highlights the innovations that shape the future of oncology trials, such as:

•    Precision Oncology & Biomarker-Driven Therapies
•    CAR-T & Cellular Immunotherapy Trials
•    Targeted Cancer Therapeutics Development
•     Oncology Patient Recruitment & Retention
•     Real-World Evidence in Cancer Treatment